Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Goos Laverman"'
Autor:
Jody Geerts, Marcel Pieterse, Goos Laverman, Femke Waanders, Nicole Oosterom, Jacqueline Slegten, Elske Salemink, Christina Bode
Publikováno v:
JMIR Formative Research, Vol 7, p e43636 (2023)
BackgroundFatigue is an important symptom for many patients, including patients with kidney disease. Cognitive biases, such as attentional bias and self-identity bias, are thought to influence fatigue. Cognitive bias modification (CBM) training is a
Externí odkaz:
https://doaj.org/article/ef749dd8e54140f8ac48d1082773abdb
Autor:
Jody Geerts, Marcel Pieterse, Goos Laverman, Femke Waanders, Nicole Oosterom, Jacqueline Slegten, Elske Salemink, Christina Bode
BACKGROUND Fatigue is an important symptom for many patients, including patients with kidney disease. Cognitive biases, such as attentional bias and self-identity bias, are thought to influence fatigue. Cognitive bias modification (CBM) training is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::150d739e186bc4198b5d3e185a6de17f
https://doi.org/10.2196/preprints.43636
https://doi.org/10.2196/preprints.43636
Autor:
Eclaire Antoinette Gonnelien Hietbrink, Niala den Braber, Anouk Middelweerd, Annemieke, Annemieke Konijnendijk, Konijnendijk, Miriam Vollenbroek-Hutten, Goos Laverman
Publikováno v:
10th Supporting Health by Technology 2021
University of Twente Research Information (Pure Portal)
University of Twente Research Information (Pure Portal)
Background: Diabetes mellitus is one of the most common non-communicable diseases worldwide. In patients with Diabetes Mellitus type 2 (T2DM), a healthy lifestyle is essential as it has positive effects on glucose regulation and therefore reduces the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::18072033ccf4cea080508111979fa9f4
https://research.utwente.nl/en/publications/e21f9c11-b9c9-4458-9628-cb5b4cd7f11e
https://research.utwente.nl/en/publications/e21f9c11-b9c9-4458-9628-cb5b4cd7f11e
Autor:
Abdulbaki Kumbasar, Pieter Gillard, Miguel Urina, Oner Ozdogan, Jonathan Barratt, Erik Penne, Ru San Tan, Carlos Eduardo Poli de Figueiredo, Bertrand Cariou, Trine Elisabeth Finnes, Sofia Malyutina, Andreas Kistler, Ciprian Constantin, Ruslan Sardinov, Dominique Guerrot, Goos Laverman, Jingmei Li, Alessia Fornoni, Konstantin Nikolaev, Gunnar Gislason, Asad Bhorat, Idalina Beirão, Markus Van der Giet, Nataliia Pashkovska, Ilona Kurnatowska, Ivan Vyshnyvetskyy, Mario Cozzolino, Maria Isabel Troya
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Bakris, George L; Agarwal, Rajiv; Anker, Stefan D; Pitt, Bertram; Ruilope, Luis M; Nowack, Christina; Kolkhof, Peter; Ferreira, Anna C; Schloemer, Patrick; Filippatos, Gerasimos (2019). Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. American journal of nephrology, 50(5), pp. 333-344. Karger 10.1159/000503713
Universidad Europea (UEM)
Bakris, George L; Agarwal, Rajiv; Anker, Stefan D; Pitt, Bertram; Ruilope, Luis M; Nowack, Christina; Kolkhof, Peter; Ferreira, Anna C; Schloemer, Patrick; Filippatos, Gerasimos (2019). Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial. American journal of nephrology, 50(5), pp. 333-344. Karger 10.1159/000503713
Background: Among diabetics, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality, and progression of their underlying disease. Finerenone is a novel, non-steroidal, selective mineralocorticoid-recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0b00b79939a833dc491c37063eb15b
http://hdl.handle.net/11268/8561
http://hdl.handle.net/11268/8561
Autor:
Giuseppe Remuzzi, Goos Laverman
Publikováno v:
Journal of Hypertension. 21:1625-1626